Bone-building drug which prevents fractures in people with osteoporosis approved for use in UK – here’s how it works

By Tatiane Vilaca, Postdoctoral Research Associate, School of Medicine and Population Health, University of Sheffield
Richard Eastell, Professor of Bone Metabolism, University of Sheffield

A new anti-osteoporosis drug has just been approved for use in the UK. The drug, called abaloparatide, is licensed for post-menopausal women with osteoporosis and a very high risk of fractures. Abaloparatide’s approval could benefit more than 14,000 women in the UK who are at serious risk of bone fracture.

Osteoporosis affects about 3.8…

Read complete article

~	At Melaka Art & Performance Festival I watched dancers overcome by a trance in the rain, and the smoke

~	Australia’s construction industry needs more hands on deck – so why is it ignoring skilled migrant women?

~	South Australia is proposing a law to ban kids under 14 from social media. How would it work?

~	What is 3-phase power? And how do I know if my house needs it?

~	MSG is back. Is the idea it’s bad for us just a myth or food science?

~	‘Didn’t care enough’: here’s what the Royal Commission into Defence and Veteran Suicide found

~	Empowering Minds: Human Rights Education, Literacy and the Right to Education

~	UN Rights Council: Advance Accountability for Abuses in Afghanistan

~	WHO: Pandemic Pact Risks Repeating Covid-19 Failures

~	‘Where in God’s name did all that anger come from?’: a psychological thriller for women who refuse to be broken